, Neurobiology of Disease, vol.129, pp.217-233, 2019.
, Amandine Descat: LC-MS/MS quantification of the compound. Sabiha Eddarkaoui: Design and performance of the biological assays. Caroline Evrard: Cell assays. Amaury Farce: Molecular modeling. Marion Gay: Compounds synthesis. Malika Hamdane: Cellular model. Mostafa Kouach: LC-MS/MS quantification of the compound. Paul-Emmanuel Larchanché: Compounds synthesis. Cyril Laurent: Biochemical analyses of animal models. Nicolas Lefur: Compounds design and synthesis. Patricia Melnyk: Co-design the study and writing of the manuscript. Hélène Obriot: Biochemical analyses of animal models. Nicolas Sergeant: Co-design of the study and writing of the manuscript, Authors contribution David Blum: Design of the study and analysis of data. Luc Buée: Design of the study and wrote the manuscript. Valérie Buée-Scherrer: Analyses of biochemical data. Raphaelle Caillerez: Histological and stereological study. Pascal Carato: Structure activity relationship study
Signature ? amyloid profiles are produced by different ?-secretase complexes, J. Biol. Chem, vol.289, pp.4346-4355, 2014. ,
Sulfate Salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, Preparation Thereof and Use of the Same, 2012. ,
Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease, J. Biol. Chem, vol.288, pp.17495-17507, 2013. ,
Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease, Curr. Alzheimer Res, vol.6, pp.152-157, 2009. ,
Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology, Neurobiol. Dis, vol.43, pp.486-494, 2011. ,
Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes, PLoS One, issue.4, p.4843, 1999. ,
Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease, PLoS One, vol.8, issue.2, p.56870, 2013. ,
Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease, Arch. Pharm, vol.346, pp.865-871, 2013. ,
Alzheimer's disease drug development pipeline: 2017. Alzheimer's Dement, Transl. Res. Clin. Interv, vol.3, pp.367-384, 2017. ,
Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process, Physiol. Rev, vol.90, pp.465-494, 2010. ,
AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo, Sci. Rep, vol.6, 2016. ,
Revising the definition of Alzheimer's disease: a new lexicon, Lancet Neurol, vol.9, pp.1118-1127, 2010. ,
A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol, vol.7, pp.88-90, 1961. ,
Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting, J. Vis. Exp, vol.86, 2014. ,
Synthesis and in-vitro anticancer evaluation of bistacrine congeners, J. Pharm. Pharmacol, vol.53, pp.83-88, 2001. ,
Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway, Mol. Neurodegener, vol.7, pp.48-60, 2012. ,
, Neurobiology of Disease, vol.129, pp.217-233, 2019.
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models, Cell, vol.142, pp.387-397, 2010. ,
Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission, Neurobiol. Learn. Mem, vol.95, issue.3, pp.296-304, 2011. ,
LC3-and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells, Methods, vol.75, pp.13-18, 2015. ,
Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease, Bioorg. Med. Chem, vol.21, pp.4559-4569, 2013. ,
A 2A adenosine receptor deletion is protective in a mouse model of Tauopathy, Mol. Psychiatry, vol.21, issue.1, pp.97-107, 2016. ,
Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment, Anesthesiology, vol.116, pp.779-787, 2012. ,
Alzheimer's disease: clinical trials and drug development, Lancet Neurol, vol.9, pp.702-716, 2010. ,
Use of 1,4-bis(3-aminopropyl) Piperazine Derivatives in Therapy, p.51489, 2006. ,
Chloroquine and chloroquine related compounds as a model for the design of anti-Alzheimer compounds, ACS Chem. Neurosci, vol.6, pp.559-569, 2015. ,
Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease, Curr. Med. Chem, vol.15, pp.2433-2455, 2008. ,
Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation, Neurobiol. Aging, vol.34, pp.1759-1771, 2013. ,
The role of autophagy in neurodegenerative diseases, Nat. Med, vol.19, pp.983-997, 2013. ,
The physiology of the ?-amyloid precursor protein intracellular domain AICD, J. Neurochem, vol.120, pp.109-124, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00724579
The autophagy-related protein beclin1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice, J. Clin. Invest, vol.118, pp.2190-2199, 2008. ,
Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB, EMBO Mol. Med, vol.6, pp.1142-1160, 2014. ,
Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease, Acta Neuropathol, vol.129, pp.895-907, 2015. ,
Synthesis and in vitro and in vivo antimalarial activity of N1-(7-Chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives, J. Med. Chem, vol.46, pp.542-557, 2003. ,
Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications, J. Neurochem, vol.69, issue.2, pp.834-844, 1997. ,
Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively « exon 10 » isoforms, J. Neurochem, vol.72, pp.1243-1249, 1999. ,
Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease, J. Neurochem, vol.81, pp.663-672, 2002. ,
Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases, J. Neurosci, vol.29, pp.13578-13588, 2009. ,
Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau, Acta Neuropathol, vol.129, pp.895-907, 2015. ,
The Amyloid Precursor Protein is rapidly transported from the Golgi apparatus to the lysosome and where it is processed into beta-amyloid, Mol. Brain, vol.7, pp.54-71, 2014. ,
Targeting phospho-Ser422 by active Tau immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach, Curr. Alzheimer Res, vol.9, pp.397-405, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00664452
Identification and biology of ?-secretase, J. Neurochem, vol.120, pp.34-45, 2012. ,
Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies, J. Biol. Chem, vol.282, pp.18197-18205, 2007. ,
Cyclopamine modulates ?-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation, J. Biol. Chem, vol.289, pp.33258-33274, 2014. ,
Snapin-mediated BACE1 retrograde transport is essential for its degradation in lysosomes and regulation of APP processing in neurons, Cell Rep, vol.6, pp.24-31, 2014. ,
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease, Nat. Med, vol.20, pp.1254-1262, 2014. ,
, Neurobiology of Disease, vol.129, pp.217-233, 2019.